These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 3843542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Naloxone administration impairs autoshaped learning.
    Messing RB, Allen SJ, Aanonsen L, Sparber SB.
    Behav Neural Biol; 1989 Jan; 51(1):34-45. PubMed ID: 2705981
    [Abstract] [Full Text] [Related]

  • 5. Effects of peripherally administered arginine-vasopressin on learning, retention and forgetting in mice.
    Alescio-Lautier B, Soumireu-Mourat B.
    Behav Brain Res; 1990 Dec 14; 41(2):117-28. PubMed ID: 2288666
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats.
    Packard MG, Ettenberg A.
    Regul Pept; 1985 May 14; 11(1):51-63. PubMed ID: 4011956
    [Abstract] [Full Text] [Related]

  • 8. Differential effects of DGAVP on acquisition and extinction of active avoidance behavior.
    Skopkova J, Croiset G, De Wied D.
    Peptides; 1991 May 14; 12(3):471-5. PubMed ID: 1923926
    [Abstract] [Full Text] [Related]

  • 9. Colchicine-induced alterations of reference memory in rats: role of spatial versus non-spatial task components.
    Nanry KP, Mundy WR, Tilson HA.
    Behav Brain Res; 1989 Oct 01; 35(1):45-53. PubMed ID: 2803543
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Failure of vasopressin to enhance memory in a passive avoidance task in rats.
    Sahgal A, Keith AB, Wright C, Edwardson JA.
    Neurosci Lett; 1982 Jan 22; 28(1):87-92. PubMed ID: 7063145
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of AVP and DGAVP on the exploratory activity of rats.
    Skopková J, Lát J, Dvorská I, Hrbas P, Radil T.
    Peptides; 1987 Jan 22; 8(5):785-90. PubMed ID: 3432126
    [Abstract] [Full Text] [Related]

  • 16. Behavioral effects of peripheral administration of arginine vasopressin: a review of our search for a mode of action and a hypothesis.
    Le Moal M, Dantzer R, Mormède P, Baduel A, Lebrun C, Ettenberg A, van der Kooy D, Wenger J, Deyo S, Koob GF.
    Psychoneuroendocrinology; 1984 Jan 22; 9(4):319-41. PubMed ID: 6514931
    [Abstract] [Full Text] [Related]

  • 17. Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin.
    Ettenberg A, Le Moal M, Koob GF, Bloom FE.
    Pharmacol Biochem Behav; 1983 Apr 22; 18(4):645-7. PubMed ID: 6867069
    [Abstract] [Full Text] [Related]

  • 18. Vasopressin metabolite neuropeptide facilitates simultaneous temporal processing.
    Meck WH.
    Behav Brain Res; 1987 Feb 22; 23(2):147-57. PubMed ID: 3566908
    [Abstract] [Full Text] [Related]

  • 19. Enhancement and impairment of memory retrieval by a vasopressin metabolite: an interaction with the accessibility of the memory.
    Strupp BJ, Bunsey M, Bertsche B, Levitsky DA, Kesler M.
    Behav Neurosci; 1990 Apr 22; 104(2):268-76. PubMed ID: 2346622
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.